Respectfully disagree mewards.
We all can name companies in the technology, medical technology, pharmaceutical and other spaces with $0 revenues, very deeply in debt, huge O/S counts, average management teams (nothing to write home about like at nFusz), yet they have market caps and share prices that are between 10-50 times ours. Why?
As Rory said, it’s based on future potential earnings, not today.
Again, we have 0% debt, amazing and disruptive products, experienced/savvy managment team, distribution partnerships established with Oracle/Netsuite, Marketo and others, and a tight float and O/S. This is a dream come true for so many.
I know what I own and what I own, compared to other standards, is severely undervalued in my opinion.
Telx, Google, Facebook, nFusz, Apple...